Literature DB >> 11274814

Effect of disintegrants with different hygroscopicity on dissolution of Norfloxacin/Pharmatose DCL 11 tablets.

J López-Solís1, L Villafuerte-Robles.   

Abstract

This paper reports the effect of disintegrant hygroscopicity on dissolution of tablets obtained by compression at 85 MPa of mixtures of Norfloxacin and different proportions of a disintegrant (Starch 1500, PVP XL 10 or Croscarmellose sodium) and a diluent (Pharmatose DCL 11). Dissolution behavior was evaluated according to USP 23, apparatus 2 (paddle) at 50 rpm and using 750 ml acetate buffer solution of pH 4, at 37 degrees C, as medium. Norfloxacin added of increasing proportions, in a given range, of each disintegrant or the diluent increased the drug dissolved. Addition of increasing proportions of Pharmatose DCL 11 to Norfloxacin with 5% of the high hygroscopic Starch 1500 reduced the dissolution improvement effect of Pharmatose DCL 11. Addition of 5% Pharmatose DCL 11 to tablets of the middle hygroscopic Croscarmellose sodium and Norfloxacin slightly reduced the Croscarmellose sodium dissolution promoting effect, while addition of 15% Pharmatose DCL 11 to tablets of the low hygroscopic PVP XL 10 and Norfloxacin showed no inhibition but potentiated substantially the dissolution of Norfloxacin. These effects were attributed to competition for the available water in the tablet and to different water consume, for dissolution or hydration, by the diluent and the disintegrants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274814     DOI: 10.1016/s0378-5173(01)00584-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.

Authors:  Sameer G Late; Ajay K Banga
Journal:  AAPS PharmSciTech       Date:  2010-11-18       Impact factor: 3.246

2.  Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.

Authors:  Niraj S Trasi; Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-07-07       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.